Summary
Two IgE-producing hybridomas were established from spleen cells of Balb/c mice, which had been immunized with mouse mammary tumor virus (MMTV). These IgE monoclonal antibodies (mAbs) reacted specifically with the major envelope glycoprotein (gp36) of MMTV, as established by the immunoblot assay and by passive cutaneous anaphylaxis. The effect of the IgE mAbs (produced by clone A8) on the growth of the MMTV-secreting mammary adenocarcinoma H2712 was investigated in syngeneic C3H/HeJ mice. The mice were inoculated s.c. with either 105 (≈100 × LD50) or 106 (≈1000 × LD50) tumor cells and received repeated i.p. injections of 25 µg anti-gp36 IgE mAbs at 4-day intervals for 8 weeks. This treatment prevented the development of subcutaneous tumors in 50% of the animals. Similar protection was observed when the tumor cells (105/animal) were injected i.p. 4 days prior to the beginning of the i.p. treatment consisting of injections of 25 µg mAbs at 4-day intervals for 6 weeks. However, these mAbs did not protect C3H/HeJ mice against the MMTV-negative MA16/c carcinoma cells. Hence, these results support the view that IgE-mediated cytotoxic mechanisms may play an immunologically specific antitumor surveillance role and that laboratory-induced antitumor IgE mAbs have the potential of specific therapeutic agents for in vivo destruction of tumor cells.
Similar content being viewed by others
References
Allegra J, Lipton A, Harvey H, Luderer J, Brenner D, Mortel R, Demers L, Gillin M, White D, Trautlein J (1976) Decreased prevalence of immediate hypersensitivity (atopy) in a cancer population. Cancer Res 36: 3225
Arbesman CE, Wypych JI, Reisman RE (1973) Serum IgE in human diseases. In: Mechanisms in allergy, reagin-mediated hypersensitivity. Dekker, New York, p 163
Augustin R, Chandradasa KD (1971) IgE levels and allergic skin reactions in cancer and non-cancer patients. Int Arch Allergy Appl Immunol 41: 141
Bartholomaeus WM, Keast D (1972) Reaginic antibody to tumor and alloantigens in mice. Nature 239: 206
Berczi I, Holford-Strevens V, Warsi ZH, McMorris LS, Thorlakson RH, Thorlakson TH, Sehon AH (1983) Tumor-reactive IgE antibodies in plasma of patients with gastrointestinal carcinomas. Cancer Immunol Immunother 14: 180
Black MM, Leis HP (1971) Cellular responses to autologous breast cancer tissue. Correlation with stage and lymphoreticuloendothelial reactive. Cancer 28: 263
Black MM, Leis HP Jr (1973) Cellular responses to autologous breast cancer tissue. Sequential observations. Cancer 32: 384
Broom BC, Alexander P (1975) Rat tumor allografts evoke anaphylactic antibody responses. Immunology 28: 1033
Bross IDJ, Natarajan N (1972) Leukemia from low-level radiation. Identification of susceptible children. N Engl J Med 287: 107
Burtin C, Scheinmann P, Salomon JC, Lespinats G, Frayssinet C, Lebel B, Canu P (1981) Increased tissue histamine in tumour-bearing mice and rats. Br J Cancer 43: 684
Burtin C, Scheinmann P, Salomon JC, Lespinats G, Loisillier F, Canu P (1981) The influence of intraperitoneal injections of histmaines on tumor growth in fibrosarcoma-bearing mice. Cancer Lett 12: 195
Burtin C, Scheinmann P, Salomon JC, Lespinats G, Canu P (1982) Decrease in tumour growth by injections of histamine or serotonin in fibrosarcoma bearing mice: influence of H1 and H2 histamine receptors. Br J Cancer 45: 54
Burtin C, Noirot C, Paupe J, Scheinmann P (1983) Decreased blood histamine levels in patients with solid malignant tumours. Br J Cancer 47: 367
Burtin C, Ponvert C, Fray A, Scheinmann P, Lespinats G, Loridon B, Canu P, Paupe J (1985) Inverse correlation between tumor incidence and tissue histamine levels in W/W/, W/+ and +/+ mice. JNCI 74: 671
Capron M (1988) Eosinophils in diseases: receptors and mediators: In: Progress in allergy and clinical immunology (Proc. 13th Int Cong Allergy Clin Immunol). Hogrefe & Huber, Toronto, p 6
Chaudhary VK (1990) A rapid method of cloning functional variable-region antibody genes inE. coli as single chain immunotoxins. Second Int Symp Immunotoxins, Lake Buena Vista, Fla.
Conrad DH (1989) Low affinity IgE (FcE R II) receptors. Clin Rev Allergy 7: 165
Daams JH, Hageman P, Calafat J, Bentvelzen P (1973) Antigenic structure of murine mammary tumour viruses. Eur J Cancer 9: 567
Fisherman EW (1960) Does the allergic diathesis influence malignancy? J Allergy 31: 74
Galfre G, Milstein C (1981) Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol 73: 1
Gershoni JM (1987) Protein blotting: a manual. Methods Biochem Anal 33: 1
Grace JT, Kondo T (1958) Investigations of host resistance in cancer patients. Ann Surg 148: 633
Haba S, Ovary Z, Nisonoff A (1985) Clearance of IgE from serum of normal and hybridoma-bearing mice. J Immunol 134: 3291
Hirano T, Hom C, Ovary Z (1983) Half life of murine IgE antibodies in the mouse. Int Arch Allergy Appl Immunol 71: 182
Hoogenraad N, Helman T, Hoogenraad J (1983) The effect of preinjection of mice with pristane on ascites tumour formation and monoclonal antibody production. J Immunol Methods 61: 317
Jacobs D, Landon J, Houri M, Merrett TG (1972) Circulating levels of immunoglobulin E in patients with cancer. Lancet II: 1059
Keller R, Ogilvie BM, Simpson E (1971) Tumour growth in nemotode-infected animals. Lancet I: 678
Kelly KA, Lang GM, Bundesen PG, Holford-Strevens V, Bottcher I, Sehon AH (1980) The development of a radioallergosorbent test (RAST) for murine IgE antibodies. J Immunol Methods 39: 317
Kenten JH, Molgaard HV, Houghton M, Derbyshire, RB, Viney J, Bell LO, Gould H (1982) Cloning and sequence determination of the gene for the human immunoglobulin ε chain expressed in a myeloma cell line. Proc Natl Acad Sci USA 79: 6661
Kenten J, Helm B, Ishizaka T, Cattini P, Gould H (1984) Properties of a human immunoglobulin ε-chain fragment synthesized inEscherichia coli. Proc Natl Acad Sci USA 81: 2955
Kernan NA, Byers V, Scannon PJ, Mischak RP, Brochstein MD, Flomenberg N, Dupont B, O'Reilly RJ (1988) Treatment of steroidresistant acute graft-vs-host disease by in vivo administration of an anti-T-cell ricin A chain immunotoxin. J Am Med Assoc 259: 3154
Lee N, Zhang SQ, Testa D (1988) A rapid multicolor Western blot. J Immunol Methods 106: 27
Likhite VV (1974) The delayed and lasting rejection of mammary adenocarcinoma cell tumors in DBA/2 mice with use of killedBordetella pertussis. Cancer Res 34: 1027
Liu F-T, Bohn JW, Ferry EL, Yamamoto H, Molinardo CA, Sherman LA, Klinman NR, Katz DH (1980) Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization. J Immunol 124: 2728
Logan J, Saker DN (1953) The incidence of allergic disorders in cancer. NZ Med J 52: 210
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265
Lynch NR, Salomon JC (1977) Passive local anaphylaxis: demonstration of antitumor activity and complementation of intratumor BCG. JNCI 58: 1093
Maiti PK, Lang GM, Sehon AH (1988) Tolerogenic conjugates of xenogeneic monoclonal antibodies with monomethoxypolyethylene glycol: I. Induction of long-lasting tolerance to xenogeneic monoclonal antibodies. Int J Cancer [Suppl] 3: 17
McKay WD (1966) The incidence of allergic disorders and cancer. Br J Cancer 20: 434
Meers PD (1973) Allergy and cancer. Lancet I: 884
Metzger H (1988) Molecular aspects of receptors and binding factors for IgE. Adv Immunol 43: 277
Reichmann L, Clark M, Waldmann H, Winter G (1988) Reshaping human antibodies for therapy. Nature 332: 323
Scheinmann P, Lebel B, Lynch NR, Salomon JC, Paupe JR, Burtin C (1979) Histamine levels in blood and other tissues of male and female C3H mice: II. Mice carrying a 3-methyl-cholanthrene-induced tumor. Agents Action 9: 95
Sehon AH (1982) Suppression of IgE antibody responses with tolerogenic conjugates of allergens and haptens. Prog Allergy 32: 161
Shoenfeld Y, Amnon H, Tal R, Smorodinsky NI, Lavie G, Mor C, Schteren S, Mammon Z, Pinkhas J, Keydar T (1987) Human monoclonal antibodies derived from lymph nodes of a patient with breast carcinoma react with MuMTV polypeptides. Cancer 59: 43
Stage DE, Mannik M (1974) Covalent binding of molecules to CNBr-activated agarose: parameters relevant to the activation and coupling reactons. Biochem Biophys Res Commun 343: 382
Sweeney WT, Seibel HR (1973) Histamine release from peritoneal mast cells of tumor susceptible rats following periods of tumor growth and sensitization with tumor antigen andB. pertussis. Int Arch Allergy 45: 789
Tsang VCW, Peralta JM, Simons AR (1983) Enzyme-linked immunoelectro-transfer blot techniques (EITB) for studying the specificities of antigens and antibodies separated by gel electrophoresis. Methods Enzymol 92: 377
Waldmann TA, Bull JM, Bruce RM, Broder S, Jost MC, Balestra ST, Suer ME (1974) Serum immunoglobulin E levels in patients with neoplastic disease. J Immunol 113: 379
Weatherly NF (1970) Increased survival of Swiss mice given sublethal injections ofTrichinella spiralis. J Parasitol 56: 748
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nagy, E., Berczi, I. & Sehon, A.H. Growth inhibition of murine mammary carcinoma by monoclonal IgE antibodies specific for the mammary tumor virus. Cancer Immunol Immunother 34, 63–69 (1991). https://doi.org/10.1007/BF01741326
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01741326